Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis

Intestinal microbiota dysbiosis is an established characteristic of ulcerative colitis (UC). Regulating the gut microbiota is an attractive alternative UC treatment strategy, considering the potential adverse effects of synthetic drugs used to treat UC. Kaempferol (Kae) is an anti-inflammatory and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yifan, Li, Xinyi, Xu, Fengying, Zhao, Shimin, Wu, Xuemei, Wang, Yuzhen, Xie, Jiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339999/
https://www.ncbi.nlm.nih.gov/pubmed/34367139
http://dx.doi.org/10.3389/fimmu.2021.679897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339999/
https://www.ncbi.nlm.nih.gov/pubmed/34367139
http://dx.doi.org/10.3389/fimmu.2021.679897

Ejemplares similares